Transgene Biotek Limited

BSE:526139 Stock Report

Market Cap: ₹493.3m

Transgene Biotek Management

Management criteria checks 2/4

Transgene Biotek's CEO is Koteswara Kanuru, appointed in Mar 2020, has a tenure of 4.67 years. directly owns 21.65% of the company’s shares, worth ₹106.79M. The average tenure of the management team and the board of directors is 5.5 years and 7.3 years respectively.

Key information

Koteswara Kanuru

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.7yrs
CEO ownership21.6%
Management average tenure5.5yrs
Board average tenure7.3yrs

Recent management updates

Recent updates


CEO

Koteswara Kanuru (82 yo)

4.7yrs

Tenure

Dr. Koteswara Rao Kanuru serves as the Managing Director of Transgene Biotek Limited since March 4, 2020 and served as its Compliance Officer since May 29, 2015. Dr. Kanuru served as the Compliance Officer...


Leadership Team

NamePositionTenureCompensationOwnership
Koteswara Kanuru
Chairman & MD4.7yrsno data21.65%
₹ 106.8m
Chowdari Prasad
Chief Financial Officer5.5yrs₹456.00kno data
Ankita Jain
Company Secretary & Compliance Officer5.5yrs₹240.00kno data

5.5yrs

Average Tenure

Experienced Management: 526139's management team is seasoned and experienced (5.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Koteswara Kanuru
Chairman & MD13.2yrsno data21.65%
₹ 106.8m
L. Sujana Kadiam
Non-Executive Independent Woman Director9.6yrs₹20.00kno data
G. Kumar
Non-Executive Independent Director5yrs₹20.00kno data
Swetha Marri
Independent Director4.4yrs₹20.00kno data

7.3yrs

Average Tenure

41yo

Average Age

Experienced Board: 526139's board of directors are considered experienced (7.3 years average tenure).